BN/OrlIcoCrlf |
plasma norepinephrine level |
control condition |
Klimes I, et al., Physiol Genomics 2005 Jan 20;20(2):183-7 |
blood norepinephrine amount |
not specified |
123 days
| 10 |
232.0 |
pg/ml |
15.81 |
50.0 |
radioenzymatic assay |
0 |
|
0 |
|
|
66074 |
70 |
HTG |
plasma norepinephrine level |
physical restraint on immobilization board (for 2 hours) |
Klimes I, et al., Physiol Genomics 2005 Jan 20;20(2):183-7 |
blood norepinephrine amount |
not specified |
123 days
| 10 |
2063.0 |
pg/ml |
210.29 |
665.0 |
radioenzymatic assay |
0.0 |
|
0 |
|
|
66079 |
70 |
HTG |
plasma norepinephrine level |
physical restraint on immobilization board (for 0.3 hours) |
Klimes I, et al., Physiol Genomics 2005 Jan 20;20(2):183-7 |
blood norepinephrine amount |
not specified |
123 days
| 10 |
2987.0 |
pg/ml |
192.9 |
610.0 |
radioenzymatic assay |
0 |
|
0 |
|
|
66077 |
70 |
HTG |
plasma norepinephrine level |
control condition |
Klimes I, et al., Physiol Genomics 2005 Jan 20;20(2):183-7 |
blood norepinephrine amount |
not specified |
123 days
| 10 |
437.0 |
pg/ml |
47.12 |
149.0 |
radioenzymatic assay |
0 |
|
0 |
|
|
66075 |
70 |
SD |
plasma norepinephrine level |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
98 days
| 8 |
93.0 |
pg/ml |
12.0 |
33.94 |
enzyme linked immunosorbent assay |
0.0 |
sham ACF |
28 |
days |
pl bk |
99283 |
2278 |
SD |
plasma norepinephrine level |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
175 days
| 10 |
159.0 |
pg/ml |
17.0 |
53.76 |
enzyme linked immunosorbent assay |
0.0 |
ACF |
105 |
days |
|
99286 |
2278 |
SD |
plasma norepinephrine level |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
175 days
| 8 |
102.0 |
pg/ml |
16.0 |
45.25 |
enzyme linked immunosorbent assay |
0.0 |
sham ACF |
105 |
days |
|
99285 |
2278 |
BN/OrlIcoCrlf |
plasma norepinephrine level |
physical restraint on immobilization board (for 2 hours) |
Klimes I, et al., Physiol Genomics 2005 Jan 20;20(2):183-7 |
blood norepinephrine amount |
not specified |
123 days
| 10 |
942.0 |
pg/ml |
78.11 |
247.0 |
radioenzymatic assay |
0 |
|
0 |
|
|
66078 |
70 |
SD |
plasma norepinephrine level |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
blood norepinephrine amount |
male |
98 days
| 9 |
89.0 |
pg/ml |
8.0 |
24.0 |
enzyme linked immunosorbent assay |
0.0 |
ACF |
28 |
days |
|
99284 |
2278 |
BN/OrlIcoCrlf |
plasma norepinephrine level |
physical restraint on immobilization board (for 0.3 hours) |
Klimes I, et al., Physiol Genomics 2005 Jan 20;20(2):183-7 |
blood norepinephrine amount |
not specified |
123 days
| 10 |
1287.0 |
pg/ml |
68.94 |
218.0 |
radioenzymatic assay |
0 |
|
0 |
|
|
66076 |
70 |